Suppression of hepatoma carcinoma cell bel-7404 by small molecule XIAP inhibitor embelin through blocking NF-κB signaling pathway

Progress in Biochemistry and Biophysics

Volumn 39, Issue 2, 2012, Pages 161-167

  Wang, Shi Bing ^a   Lei, Wen ^a   Xu, Yan Hua ^a   Gu, Oke Ni ^a   Wang, Yi Gang ^a  

^a ZHEJIANG SCI TECH UNIVERSITY   (China)

Author keywords

Apoptosis; Caspase NF B; Hepatoma carcinoma cell; Small molecule XIAP inhibitor

Indexed keywords

EID: 84860873587     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2011.00300     Document Type: Article

References (17)

1. Deveraux Q L, Takahashi R, Salvesen G S, et al. X-linked IAP is a direct inhibitor of cell-death proteases. Nature, 1997, 388 (6639): 300-304 (Pubitemid 27317977)
2. Nikolovska-Coleska Z, Xu L, Hu Z, et al. Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database. J Med Chem, 2004, 47(10): 2430-2440 (Pubitemid 38580082)
3. Shishodia S, Aggarwal B B. Nuclear factor-kappaB: a friend or a foe in cancer. BiochemPharmacol, 2004, 68(6): 1071-1080 (Pubitemid 39094272)
4. Yang J Y, Zhang S Z, Guo H, et al. Prog Biochem Biophys, 2007, 34(6): 604-610
5. Holcik M, Korneluk R G. XIAP. The guardian angel. Nat Rev Mol Cell Bio, 2001, 2(7): 550-556
6. Chen F H, Qu H Y, Sui G J. Chin J Lung Cancer, 2008, 11 (3): 368-372
7. Shiraki K, Sugimoto K, Yamanaka Y, et al. Overexpression of X-linked inhibitor of apoptosis in human hepatocellular carcinoma. Int J Mol Med, 2003, 12(5): 705-708
8. Dean E, Jodrell K, Connolly K, et al. Phase I trail of AEG35156 administered as a 7-day and 3-day continuoud intravenous infusion in patients with advanced refractory cancer. J Clin Oncol, 2009, 27(10): 1660-1666
9. Wang R, Li B, Wang X, et al. Inhibiting XIAP expression by RNAi to inhibit proliferation and enhance radiosensitivity in laryngeal cancer cell line. Auris Nasus Larynx, 2009, 36(3): 332-339
10. Mohd A B, Huang I. Expression sensitives ovarian cancer cells to cell death mediated by XIAP inhibition. Br J Cancer, 2009, 101(2): 269-277
11. Yang L, Mashima T, Sato S, et al. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginineconjugated Smac peptide. Cancer Res, 2003, 63(4): 831-837 (Pubitemid 36231984)
12. Shen L Q, Xu X, Lv F L, et al. Prog BiochemBiophys. 2002, 29(3): 368-371
13. Hofer-Warbinek R, Schmid J A, Stehlik C, et al. Activation of NF-κB by XIAP, the x chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAKl. J Biol Chem, 2000, 275 (29): 22064-22068 (Pubitemid 30621784)
14. Nikrad M, Johnson T, Puthalalath H, et al. The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins bik and bim. Mol Cancer Ther, 2005, 4(3): 443-449 (Pubitemid 40443929)
15. Katsuda K, Kataoka M, Uno F, et al. Activation of caspase-3 and cleavage of Rb areassociated with p16-mediated apoptosis in human non-small cell lung cancer cells. Oncogene. 2002, 21 (13): 2108-2113 (Pubitemid 34270900)
16. Mistry P, Deacon K, Mistry S, et al. NF-kappaB promotes survival during mitotic cell cycle arrest. J Biol Chem, 2004, 279(2): 1482-1489
17. Fujioka S, Schmidt C, Sclabas G M, et al. Stabilization of p53 is a novel mechanism for proapoptotic function of NF-kappaB. J Biol Chem, 2004, 279(26): 27549-27559 (Pubitemid 38812596)